Laiqiang Huang

ORCID

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 10

Top Venues

Pharmaceutics

Biosensors

International journal of molecular sciences

Journal of experimental & clinical cancer research : CR

This page only lists publications with an associated author ORCID identifier.

Publications

Ting Deng, Yibo Hou, Gaoyang Lin, Chunyan Feng, Kewei Liu, Wenke Chen, Wei Wei, Laiqiang Huang, Xiaoyong Dai
A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer. Pharmaceutics 15 (3) (2023)
Ting Deng, Yibo Hou, Gaoyang Lin, Chunyan Feng, Kewei Liu, Wenke Chen, Wei Wei, Laiqiang Huang, Xiaoyong Dai
A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer. Pharmaceutics 15 (3) (2023)
Liang Ma, Ke-Wei Liu, Zhen Li, Yu-Yun Hsiao, Yiying Qi, Tao Fu, Guang-Da Tang, Di-Yang Zhang, Wei-Hong Sun, Ding-Kun Liu, Yuanyuan Li, Gui-Zhen Chen, Xue-Die Liu, Xing-Yu Liao, Yu-Ting Jiang, Xia Yu, Yang Hao, Jie Huang, Xue-Wei Zhao, Shijie Ke, You-Yi Chen, Wan-Lin Wu, Jui-Ling Hsu, Yu-Fu Lin, Ming-Der Huang, Chia-Ying Li, Laiqiang Huang, Zhi-Wen Wang, Xiang Zhao, Wen-Ying Zhong, Dong-Hui Peng, Sagheer Ahmad, Si-Ren Lan, Ji-Sen Zhang, Wen-Chieh Tsai, Yves Van de Peer, Zhong-Jian Liu
Diploid and tetraploid genomes of Acorus and the evolution of monocots. Nature communications 14 (1) (2023)
Ting Deng, Yibo Hou, Gaoyang Lin, Chunyan Feng, Kewei Liu, Wenke Chen, Wei Wei, Laiqiang Huang, Xiaoyong Dai
A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer. Pharmaceutics 15 (3) (2023)
Albert Yu, Xiaoyong Dai, Zixian Wang, Huaqing Chen, Bing Guo, Laiqiang Huang
Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 12 (2) (2022)
Ming-He Li, Ke-Wei Liu, Zhen Li, Hsiang-Chia Lu, Qin-Liang Ye, Diyang Zhang, Jie-Yu Wang, Yu-Feng Li, Zhi-Ming Zhong, Xuedie Liu, Xia Yu, Ding-Kun Liu, Xiong-De Tu, Bin Liu, Yang Hao, Xing-Yu Liao, Yu-Ting Jiang, Wei-Hong Sun, Jinliao Chen, Yan-Qiong Chen, Ye Ai, Jun-Wen Zhai, Sha-Sha Wu, Zhuang Zhou, Yu-Yun Hsiao, Wan-Lin Wu, You-Yi Chen, Yu-Fu Lin, Jui-Ling Hsu, Chia-Ying Li, Zhi-Wen Wang, Xiang Zhao, Wen-Ying Zhong, Xiao-Kai Ma, Liang Ma, Jie Huang, Gui-Zhen Chen, Ming-Zhong Huang, Laiqiang Huang, Dong-Hui Peng, Yi-Bo Luo, Shuang-Quan Zou, Shi-Pin Chen, Si-Ren Lan, Wen-Chieh Tsai, Yves Van de Peer, Zhong-Jian Liu
Genomes of leafy and leafless Platanthera orchids illuminate the evolution of mycoheterotrophy. Nature plants 8 (4) (2022)
Kun Wang, Xiaoyong Dai, Albert Yu, Chunyan Feng, Kewei Liu, Laiqiang Huang
Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Yuhong Liu, Xiaoyong Dai, Shengwei Jiang, Mulan Qahar, Chunyan Feng, Dongdong Guo, Lijun Wang, Shaohua Ma, Laiqiang Huang
Targeted Co-Delivery of Gefitinib and Rapamycin by Aptamer-Modified Nanoparticles Overcomes EGFR-TKI Resistance in NSCLC via Promoting Autophagy. International journal of molecular sciences 23 (14) (2022)
Xiaoyong Dai, Fen Sun, Kexin Deng, Gaoyang Lin, Wenjing Yin, Huaqing Chen, Dongye Yang, Kewei Liu, Yubo Zhang, Laiqiang Huang
Mallotucin D, a Clerodane Diterpenoid from Croton crassifolius , Suppresses HepG2 Cell Growth via Inducing Autophagic Cell Death and Pyroptosis. International journal of molecular sciences 23 (22) (2022)
Albert Yu, Xiaoyong Dai, Zixian Wang, Huaqing Chen, Bing Guo, Laiqiang Huang
Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12 , 109. Biosensors 12 (10) (2022)

Laiqiang Huang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Laiqiang Huang